![](/img/cover-not-exists.png)
Evaluation of the US Oncology Network's Recommended Guidelines for Therapeutic Substitution with Darbepoetin alfa 200 μg Every 2 Weeks in Both Naïve Patients and Patients Switched from Epoetin alfa
William A. Thames, Sandra L. Smith, Andrew C. Scheifele, Bin Yao, Suzana A. Giffin, Julie L. AlleyVolume:
24
Year:
2004
Language:
english
Pages:
11
DOI:
10.1592/phco.24.4.313.33180
File:
PDF, 161 KB
english, 2004